210 related articles for article (PubMed ID: 35108011)
1. Discovery of Non-Nucleotide Small-Molecule STING Agonists
Cherney EC; Zhang L; Lo J; Huynh T; Wei D; Ahuja V; Quesnelle C; Schieven GL; Futran A; Locke GA; Lin Z; Monereau L; Chaudhry C; Blum J; Li S; Fereshteh M; Li-Wang B; Gangwar S; Pan C; Chong C; Zhu X; Posy SL; Sack JS; Zhang P; Ruzanov M; Harner M; Akhtar F; Schroeder GM; Vite G; Fink B
J Med Chem; 2022 Feb; 65(4):3518-3538. PubMed ID: 35108011
[TBL] [Abstract][Full Text] [Related]
2. STING activation in cancer immunotherapy.
Su T; Zhang Y; Valerie K; Wang XY; Lin S; Zhu G
Theranostics; 2019; 9(25):7759-7771. PubMed ID: 31695799
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis and Biological Evaluation of (2',5' and 3'5'-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING).
Xie X; Liu J; Wang X
Molecules; 2020 Nov; 25(22):. PubMed ID: 33198423
[TBL] [Abstract][Full Text] [Related]
4. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy.
Shae D; Becker KW; Christov P; Yun DS; Lytton-Jean AKR; Sevimli S; Ascano M; Kelley M; Johnson DB; Balko JM; Wilson JT
Nat Nanotechnol; 2019 Mar; 14(3):269-278. PubMed ID: 30664751
[TBL] [Abstract][Full Text] [Related]
5. Innate Immune Activation by cGMP-AMP Nanoparticles Leads to Potent and Long-Acting Antiretroviral Response against HIV-1.
Aroh C; Wang Z; Dobbs N; Luo M; Chen Z; Gao J; Yan N
J Immunol; 2017 Dec; 199(11):3840-3848. PubMed ID: 29084836
[TBL] [Abstract][Full Text] [Related]
6. No magnesium is needed for binding of the stimulator of interferon genes to cyclic dinucleotides.
Smola M; Birkus G; Boura E
Acta Crystallogr F Struct Biol Commun; 2019 Sep; 75(Pt 9):593-598. PubMed ID: 31475926
[TBL] [Abstract][Full Text] [Related]
7. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING.
Zhang X; Shi H; Wu J; Zhang X; Sun L; Chen C; Chen ZJ
Mol Cell; 2013 Jul; 51(2):226-35. PubMed ID: 23747010
[TBL] [Abstract][Full Text] [Related]
8. cGAS-STING signaling in cancer immunity and immunotherapy.
Du H; Xu T; Cui M
Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
[TBL] [Abstract][Full Text] [Related]
9. Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG.
Yildiz S; Alpdundar E; Gungor B; Kahraman T; Bayyurt B; Gursel I; Gursel M
Eur J Immunol; 2015 Apr; 45(4):1170-9. PubMed ID: 25581346
[TBL] [Abstract][Full Text] [Related]
10. Design of amidobenzimidazole STING receptor agonists with systemic activity.
Ramanjulu JM; Pesiridis GS; Yang J; Concha N; Singhaus R; Zhang SY; Tran JL; Moore P; Lehmann S; Eberl HC; Muelbaier M; Schneck JL; Clemens J; Adam M; Mehlmann J; Romano J; Morales A; Kang J; Leister L; Graybill TL; Charnley AK; Ye G; Nevins N; Behnia K; Wolf AI; Kasparcova V; Nurse K; Wang L; Puhl AC; Li Y; Klein M; Hopson CB; Guss J; Bantscheff M; Bergamini G; Reilly MA; Lian Y; Duffy KJ; Adams J; Foley KP; Gough PJ; Marquis RW; Smothers J; Hoos A; Bertin J
Nature; 2018 Dec; 564(7736):439-443. PubMed ID: 30405246
[TBL] [Abstract][Full Text] [Related]
11. STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors.
Perera SA; Kopinja JE; Ma Y; Muise ES; Laskey J; Chakravarthy K; Chen Y; Cui L; Presland J; Sathe M; Javaid S; Minnihan EC; Ferguson HM; Piesvaux J; Pan BS; Zhao S; Sharma SK; Woo HC; Pucci V; Knemeyer I; Cemerski S; Cumming J; Trotter BW; Tse A; Khilnani A; Ranganath S; Long BJ; Bennett DJ; Addona GH
Mol Cancer Ther; 2022 Feb; 21(2):282-293. PubMed ID: 34815361
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer.
Corrales L; Gajewski TF
Clin Cancer Res; 2015 Nov; 21(21):4774-9. PubMed ID: 26373573
[TBL] [Abstract][Full Text] [Related]
13. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
[TBL] [Abstract][Full Text] [Related]
14. The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells.
Vasiyani H; Shinde A; Roy M; Mane M; Singh K; Singh J; Gohel D; Currim F; Vaidya K; Chhabria M; Singh R
Apoptosis; 2021 Jun; 26(5-6):293-306. PubMed ID: 33840002
[TBL] [Abstract][Full Text] [Related]
15. Development of small molecule inhibitors/agonists targeting STING for disease.
Liu K; Lan Y; Li X; Li M; Cui L; Luo H; Luo L
Biomed Pharmacother; 2020 Dec; 132():110945. PubMed ID: 33254439
[TBL] [Abstract][Full Text] [Related]
16. M335, a novel small-molecule STING agonist activates the immune response and exerts antitumor effects.
Zhao M; Fan W; Wang Y; Qiang P; Zheng Z; Shan H; Zhang M; Liu P; Wang Y; Li G; Li M; Hong L
Eur J Med Chem; 2024 Jan; 264():116018. PubMed ID: 38091891
[TBL] [Abstract][Full Text] [Related]
17. Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy.
Wu JJ; Zhao L; Hu HG; Li WH; Li YM
Med Res Rev; 2020 May; 40(3):1117-1141. PubMed ID: 31793026
[TBL] [Abstract][Full Text] [Related]
18. A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists.
Liu B; Tang L; Zhang X; Ma J; Sehgal M; Cheng J; Zhang X; Zhou Y; Du Y; Kulp J; Guo JT; Chang J
Antiviral Res; 2017 Nov; 147():37-46. PubMed ID: 28982551
[TBL] [Abstract][Full Text] [Related]
19. STING Activation and its Application in Immuno-Oncology.
Lian Y; Duffy KJ; Yang J
Curr Top Med Chem; 2019; 19(24):2205-2227. PubMed ID: 31642767
[TBL] [Abstract][Full Text] [Related]
20. STING Signaling in Cancer Cells: Important or Not?
Sokolowska O; Nowis D
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):125-132. PubMed ID: 28748479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]